CVD Toll From Sugary Drinks; Migraine Tx and Heart Risk; Baby Heart Xenotransplant?

—
Recent developments of interest in cardiovascular medicine

by
Nicole Lou, Senior Staff Writer, MedPage Today
January 7, 2025

An estimated 2.2 million new cases of type 2 diabetes and 1.2 million new cases of cardiovascular disease (CVD) each year around the world were attributed to sugar-sweetened beverages. (Nature Medicine)

With dropping temperatures in many parts of the country, the general public is reminded of the accompanying risk of heart attacks and sudden death. (WRAL, WKRC)

For selected stroke patients, late tenecteplase helped with reperfusion but not 90-day outcomes when administered during the extended time window of 4.5 to 24 hours from the last known well, according to a randomized trial from China. (Stroke)

Between 2001 and 2023, a rising prevalence of obesity in people with hypertension was observed in men and women alike. (Hypertension)

Researchers in Boston developed and validated an ECG-based artificial intelligence risk estimator for hypertension that can predict incident hypertension and identify patients at risk for related adverse events. (JAMA Cardiology)

Artificial intelligence was also used as the basis for the noninvasive detection of elevated left atrial pressures using ECG patch-monitors. (Communications Medicine)

Heart digital twin modeling flagged more abnormal site candidates for substrate-based catheter ablation for ventricular tachycardia. (Circulation)

Anumana said it is collaborating with AliveCor to combine its FDA-cleared ECG-AI LEF algorithm with the Kardia ECG devices for early detection of cardiac disease.

In a retrospective analysis of Medicare beneficiaries with migraine, initiation of anti-calcitonin gene-related peptide monoclonal antibody therapy was not associated with excess CVD risk compared with onabotulinumtoxinA. (JAMA Neurology)

Cardiac sarcoidosis was more common in those with cutaneous sarcoidosis of the nose or face, as opposed to other affected parts of the body, observational data suggested. (JAMA Dermatology)

People with more advanced breast cancer at diagnosis tended to have more prevalent CVD, based on a population-based case-control study. (JAMA Network Open)

Review finds that rural people with left ventricular assist devices (LVADs) had no worse survival rates and heart transplantation outcomes at 1 year compared with urban peers — but a higher risk of gastrointestinal bleeding, ventricular arrhythmias, LVAD complications, and stroke. (Clinical Cardiology)

Scientists trying to develop infant orthotopic cardiac xenotransplantation are at the stage of testing on a non-human primate model. (Journal of Heart and Lung Transplantation)